In any field of technology there is always money to be spent upgrading systems etc. Particularly in a field with strict regulatory controls. I don't know, but I suspect that in recent times they might have erred towards spending the minimum on such systems which has now necessitated some 'catch up' spending. Like I say, just my guess.
A long termer for me but I suspect this one will be quiet for a while. Of concern to me is their admission that they have lost share in the cord-blood business. I think the opposition have out marketed them and that will require more funds to be spent imo.
Cheers
CTE Price at posting:
47.0¢ Sentiment: LT Buy Disclosure: Held